Ikena Oncology

Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Their programs focus on key cancer driver pathways that are well-validated in scientific literature but lack approved or effective therapies and therefore have the potential to address high unmet medical needs. By leveraging their…More deep understanding of discovery chemistry, translational science, and patient-centric drug development, they have built a deep pipeline of wholly owned and partnered programs focused on genetically defined or biomarker-driven cancers, which enables them to target specific patient populations that they believe are most likely to respond to treatment with our product candidates.